Skip to content
Screener

Amgen AMGN Q1 2025 earnings

Reported May 1, 2025 · After market close

Revenue$8.1BBeat by $91.5M
EPS$4.90Beat by $0.63
Revenue estimate$8.1B
EPS estimate$4.27

Next report

Nov 3, 2026 (in a month)
Revenue estimate$10.0B
EPS estimate$5.78

Financials

Q1 2025

Income statement

See full
Revenue$8.1B+9.4%
Gross profit$5.2B+22.0%
Operating income$1.2B+18.9%
Net income$1.7B+1,631%
EPS (diluted)$3.20+1,624%

Balance sheet

See full
Cash & equivalents$508.0M+7.9%
Total debt$57.4B-10.4%
Total equity$6.2B+23.6%
Total assets$89.4B-3.9%

Cash flow

See full
Operating cash flow$1.4B+102%
CapEx$411.0M+78.7%
Free cash flow$980.0M+114%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$167.37B+9.8%
Enterprise value$224.24B+3.9%
P/E28.2×-12.3×
P/S4.9×-0.3×

Profitability

See full
Gross margin63%-3.4pp
Operating margin21.8%-1.8pp
Net margin17.4%+4.6pp
FCF margin32%+7.9pp

Returns & leverage

See full
Return on equity105.7%+33.1pp
Debt / equity9.2×-3.5×
Current ratio1.2×-0.3×

Segments

By product

See full
Other products$1.5B+7.4%
Prolia$1.1B+10.0%
Repatha$754.0M—
XGEVA$566.0M+0.9%
ENBREL$510.0M-10.1%

By segment

See full
Reportable Segment$8.1B+9.4%

By geography

See full
ROW$2.6B+8.1%

FAQ

When did Amgen report Q1 2025 earnings?
Amgen (AMGN) reported Q1 2025 earnings on May 1, 2025 after market close.
What were Amgen's Q1 2025 revenue and EPS?
Amgen reported revenue of $8.1B and eps of $4.90 for Q1 2025.
Did Amgen beat estimates in Q1 2025?
Revenue beat the consensus estimate of $8.1B by $91.5M. EPS beat the consensus estimate of $4.27 by $0.63.
How did Amgen's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.4% from $7.4B a year earlier and eps grew 23.7% from $3.96.
Where can I find Amgen's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000318154-25-000018) and the 10-Q periodic report (0000318154-25-000020) directly on SEC EDGAR. The filing index links above go to sec.gov.